Effect of Long Term Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2
Effect of Cocoa Flavanol Intake on Blood Pressure and Platelet Function in Healthy Adults, Part 2
1 other identifier
interventional
75
1 country
1
Brief Summary
Flavanols are plant-derived compounds commonly present in the human diet. Examples of flavanol-containing foods and beverages are apples, chocolate, tea, wine, berries, pomegranate and nuts. The consumption of flavanol-containing foods and beverages has been associated with improvements in cardiovascular health. In this study, the investigators hope to learn more about the effects of long term consumptions of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans. This study is a continuation of a previous study investigating the consumptions of increasing amounts of cocoa flavanols on blood pressure, platelet function and other metabolic parameters in healthy humans
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Jun 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 15, 2015
CompletedFirst Posted
Study publicly available on registry
May 19, 2015
CompletedMay 30, 2017
May 1, 2017
6 months
May 15, 2015
May 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in blood pressure
Blood pressure will be measured using standard techniques.
Baseline (day 0) and 6,12 and 14 weeks after intervention
Secondary Outcomes (3)
Change in platelet function
Baseline and 6, 12 and 14 weeks after intervention
Change in 24 h ambulatory blood pressure
Baseline (day 0) and 12 weeks after intervention
Change in metabolic parameters in blood
Baseline (day 0) and 6, 12 and 14 weeks after intervention
Other Outcomes (2)
Change in plasma concentration of cocoa flavanol metabolites
Baseline (day 0) and 6, 12 and 14 weeks after intervention
Change in plasma concentration of methylxanthines
Baseline (day 0) and 6, 12, and 14 weeks after intervention
Study Arms (2)
Control, Flavanol-free intervention
PLACEBO COMPARATORIntake of flavanol-free, macro- and micro-nutrient matched control capsules
CF intervention
ACTIVE COMPARATORIntake of capsules containing Mars Cocoa Extract Capsules manufactured by the Cocoapro® process and providing 500 mg of cocoa flavanols per capsule
Interventions
Cocoa-based, flavanol-free, control-matched capsules consumed for 12 weeks (Week 1: 2 capsules/day; Week 2: 3 capsules/day; Week 3-12: 4 capsules/day; Week 12-14: no capsule intake).
Capsules containing Mars Cocoa Extract manufactured by the Cocoapro® process and containing 500 mg of cocoa flavanols per capsule consumed for 12 weeks (Week 1: 2 capsules/day; Week 2: 3 capsules/day; Week 3-12: 4 capsules/day; Week 12-14: no capsule intake).
Eligibility Criteria
You may qualify if:
- years old
- A normal blood chemistry and liver function
- BMI \< 30 kg/m2
- previously consumed cocoa and peanut products, with no adverse reactions
You may not qualify if:
- A history of cardiovascular disease, stroke, hypertension, renal, hepatic, or thyroid disease, GI tract disorders, previous GI surgery, metabolic syndrome, diabetes, taking cholesterol-lowering medication, hormone replacement therapy, antioxidant supplements, on aspirin therapy or taking anticoagulants, or on a medically prescribed diet.
- Allergies to nuts, cocoa and chocolate products
- Vegetarian, Vegan, food faddists, individuals using non-traditional diets, on a weight loss diet or using herbal dietary supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ragle Human Nutrition Research Center, Department of Nutrition at UC Davis
Davis, California, 95616, United States
Related Publications (2)
Schroeter H, Heiss C, Spencer JP, Keen CL, Lupton JR, Schmitz HH. Recommending flavanols and procyanidins for cardiovascular health: current knowledge and future needs. Mol Aspects Med. 2010 Dec;31(6):546-57. doi: 10.1016/j.mam.2010.09.008. Epub 2010 Sep 18.
PMID: 20854838BACKGROUNDOttaviani JI, Balz M, Kimball J, Ensunsa JL, Fong R, Momma TY, Kwik-Uribe C, Schroeter H, Keen CL. Safety and efficacy of cocoa flavanol intake in healthy adults: a randomized, controlled, double-masked trial. Am J Clin Nutr. 2015 Dec;102(6):1425-35. doi: 10.3945/ajcn.115.116178. Epub 2015 Nov 4.
PMID: 26537937DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Carl L Keen, PhD
UC Davis
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2015
First Posted
May 19, 2015
Study Start
June 1, 2012
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
May 30, 2017
Record last verified: 2017-05